Sneha Das on Muck Rack

Sneha Das

Verified
Kolkata
As seen in: The Times of India, Taylor & Francis Online, DEV Community, DZone, Physical Review B, The Telegraph (India), EIN News, The Logical Indian, News Bytes, SPN News, Asia - Pacific Journal of Business Administration and
Digital Content Producer @timesofindia Ex: Lifestyle journalist @Newsbytesapp
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sneha

Contact Sneha, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Lipid signatures for a rare neurological disorder

|
By Sneha Das Verified
Chronic inflammatory demyelinating polyneuropathy, or CIDP, is an autoimmune disease where the immune system attacks and destroys the myelin sheath, a lipid-rich protective layer that covers and insulates the peripheral nerves. Although CIDP is rare and affects only two to three individuals per 100,000, those diagnosed with the disease face significant challenges due to progressive muscle weakness and loss of mobility.
Open in Who Shared Issue with article?

Cholesterol regulatory genes predict liver transplant outcomes

|
By Sneha Das Verified
Liver transplantation, or LT, is a life-saving therapy for patients with end-stage liver disease. End-stage liver disease develops from chronic liver diseases like metabolic dysfunction-associated steatotic liver disease, or MASLD, and metabolic dysfunction-associated steatohepatitis, or MASH, which is an advanced form of MASLD.
Open in Who Shared Issue with article?

The dual role of asprosin in chronic fatty liver disease

|
By Sneha Das Verified
Around 30% of the world’s population suffers from a chronic liver condition called metabolic dysfunction-associated steatotic liver disease, or MASLD, where excess fat accumulates in the organ and exceeds 5% of the organ’s total weight. Previously known as non-alcoholic fatty liver disease, MASLD is a subtype of hepatic steatosis or fatty liver disease that is not related to alcohol consumption and is the leading cause of liver-related mortality in humans.
Open in Who Shared Issue with article?
See all 12,483 licensed articles (12,485 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified